Riverfort Global Opportunities, Vadim Alexandre on Hemogenyx and Chris Bailey
Justin Waite
Vox Markets Podcast with Justin Waite
12:23, 12th September 2019

AudioBoom Player

DYOR Disclaimer

If you find this podcast useful please give it a rating and review on iTunes by clicking here

Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app


On today's Vox Markets Podcast: RiverFort Global Opportunities, Vadim Alexandre on Hemogenyx and Chris Bailey

Nick Lee, Investment Director of RiverFort Global Opportunities (RGO) FOLLOW talks through their interim results and explains their investment strategy.

RiverFort Global Opportunities (RGO) is an investment company listed on AIM, that invests by providing equity-linked debt funding to public and private small cap growth companies in the technology, natural resources, energy, financial and healthcare industry sectors.



Vadim Alexandre, Head of Healthcare at SP Angel discusses Hemogenyx (HEMO) FOLLOW

(Interview starts at 9 minutes 36 seconds)


Chris Bailey founder of Financial Orbit covers:

Lloyds (LLOY) FOLLOW

N Brown (BWNG) FOLLOW

Morrisons (MRW) FOLLOW

British American Tobacco (BATS) FOLLOW

(Interview starts at 21 minutes 33 seconds)

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Comments
info
Login or register to post comments

Recent Articles
Watchlist